Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prostatic neoplasms | D011471 | — | C61 | 1 | 8 | 4 | — | 2 | 15 |
Adenocarcinoma | D000230 | — | — | — | 1 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Castration-resistant prostatic neoplasms | D064129 | — | — | 1 | 1 | — | — | — | 2 |
Neoplasms | D009369 | — | C80 | — | 2 | — | — | — | 2 |
Carcinoma | D002277 | — | C80.0 | — | 1 | — | — | — | 1 |
Urogenital neoplasms | D014565 | EFO_0003863 | D07 | — | 1 | — | — | — | 1 |
Glandular and epithelial neoplasms | D009375 | — | — | — | 1 | — | — | — | 1 |
Prostatic diseases | D011469 | — | N42.9 | — | 1 | — | — | — | 1 |
Male genital neoplasms | D005834 | — | — | — | 1 | — | — | — | 1 |
Drug common name | Regramostim |
INN | regramostim |
Description | Regramostim is a protein pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Protein |
Drug class | colony-stimulating factors: granulocyte macrophage colony-stimulating factors (GM-CSF); colony-stimulating factors: macrophage colony-stimulating factors (M-CSF) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2107881 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | KR89Q40F01 (ChemIDplus, GSRS) |